Browse > Article

Wogonin inhibits Cytokine-induced TARC/CCL17 Expression by Suppression of NF-${\kappa}B$ activation via p38 MAP kinase Signalning Pathways in HaCaT Keratinocytes  

Jang, Seon-Il (School of Alternative Medicine & Health Science, College of Alternative Medicine, Jeonju University)
Publication Information
Journal of Physiology & Pathology in Korean Medicine / v.21, no.4, 2007 , pp. 1017-1024 More about this Journal
Abstract
Thymus and activation-regulated chemokine (TARC/CCL-17), produced by keratinocytes, is a CC chemokine known to selectively Th2 type T cells via $CCR4^+$ and is implicated in the development of atopic dermatitis (AD). TARC/CCL17 expression was induced by cytokines such as tumor necrosis factor-${\alpha}$ (TNF-${\alpha}$) and interferon-${\gamma}$ (IFN-${\gamma}$). We recently found that the wogonin, a flavone isolated from Scutellaria baicalensis, suppressed TARC expression via heme oxygenase 1 (HO1) in human keratinocytes induced with mite antigen. However, little is known about the inhibitory mechanism of wogonin on TARC/CCL-17 expression stimulated with cytokines. To investigate the inhibitory mechanism, I determined the inhibitory effects of wogonin on the activation of nuclear factor-${\kappa}B$ (NF-${\kappa}B$) and $I{\kappa}B{\alpha}$ phosphorylation, and also examined the activation of p38 MAP kainase in HaCaT keratinocytes stimulated with TNF-${\alpha}$ and IFN-${\gamma}$. Wogonin inhibited NF-${\kappa}B$-DNA complex, NF-${\kappa}B$ binding activity, and the phosphorylation of $I{\kappa}B{\alpha}$ in a dose dependent manner. Wogonin also inhibited the translocation of NF-${\kappa}B$ from cytosol to nucleus. Moreover, the phosphorylation of of p38 MAP kinase in the TNF-${\alpha}$ and IFN-${\gamma}$-stimulated HaCaT keratinocytes were suppressed by wogonin in a dose dependent manner. These results suggest that wogonin may inhibit cytokine-induced NF-${\kappa}B$ activation by $I{\kappa}B{\alpha}$ degradation via suppression of p38 MAP kinase signaling pathway in keratinocytes and modulation of wogonin signaling pathway may be beneficial for the treatment of AD.
Keywords
Atopic dermatitis; TARC/CCL17; NF-${\kappa}B$; TNF-${\alpha}$; IFN-${\gamma}$; HaCaT keratinocytes;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Baumann, L. Cosmetic dermatology: Principles & practice. McGraw-Hill, pp 3-8, 2002
2 Leung, D.Y., Boguniewicz, M., Howell, M.D., Nomura, I., Hamid, Q.A. New insights into atopic dermatitis. J. Clin. Invest. 113: 651-657, 2004   DOI
3 Trautmann, A., Akdis, M., Schmid-Grendelmeier, P., Disch, R., Brocker, E.B., Blaser, K, Akdis, C.A. Targeting keratinocyte apoptosis in the treatment of atopic dermatitis and allergic contact dermatitis. J. Allergy Clin. Immunol. 108: 839-846, 2001   DOI   ScienceOn
4 Klunker, S., Trautmann, A., Akdis, M., Verhagen, J., Schmid-Grendelmeier, P, Blaser, K, Akdis, C.A. A second step of chemotaxis after transendothelial migration: keratinocytes undergoing apoptosis release IFN-${\gamma}$ inducible protein 10, monokine induced by IFN-$\gamma$, and IFN-$\gamma$-inducible $\alpha$-chemoattractant for T cell chemotaxis toward epidermis in atopic dermatitis. J. Immunol. 171: 1078-1084, 2003   DOI
5 Zlontik, A., Yoshie, O. Chemokines: a new classification system and their role in immunity. Immunity 12: 121-127, 2004   DOI   ScienceOn
6 Kakinuma, T., Nakamura, K., Wakugawa, M., Mitsui, H., Tada, Y., Saeki, H., Torii, H., Asahina, A., Onai, N., Matsushima, K., Tamaki, K. Thymus and activation-regulated chemokine in atopic dermatitis: serum thymus and activation-regulated chemokine level is closely related with disease activity. J. Allergy Clin. Immunol. 107: 535-541, 2001   DOI   ScienceOn
7 Brandi, M.L. Flavonoids: biochemical effects and therapeutic applications. Bone Miner. 19(Suppl. 1):S3-14, 1992   DOI   ScienceOn
8 Lim, B.O., Choue, R.W., Lee, H.Y., Seong, N.S., Kim, J.D. Effect of the flavonoid components obtained from Scutellaria radix on the histamine, immunoglobulin E and lipid peroxidation of spleen lymphocytes of Sprague-Dawley rats. Biosci. Biotechnol. Biochem. 67: 1126-1129, 2003   DOI   ScienceOn
9 Chang, Y.L., Shen, J.J., Wung, B.S., Cheng, J.J., Wang, D.L. Chinese herbal remedy wogonin inhibits monocyte chemotactic protein-1 gene expression in human endothelial cells. Mol. Pharmacol. 60: 507-513, 2001
10 Lee, S.O., Jeong, Y.J., Yu, M.H., Lee, J.W., Hwangbo, M.H., Kim, C.H., Lee, I.S. Wogonin suppresses TNF-alpha-induced MMP-9 expression by blocking the NF-kappaB activation via MAPK signaling pathways in human aortic smooth muscle cells. Biochem. Biophys. Res. Commun. 351: 118-125, 2006   DOI   ScienceOn
11 Lee, B.S., Shim, S.M., Heo, J., Pae, H.O., Seo, B.Y., Han, S.Y., Sohn, D.H., Jang, S.I., Chung, H.T. Wogonin suppresses TARC expression induced by mite antigen via heme oxygenase 1 in human keratinocytes. Suppressive effect of wogonin on mite antigen-induced TARC expression. J. Dermatol. Sci. 46: 31-40, 2007   DOI   ScienceOn
12 Horikawa, T., Nakayama, T., Hikita, I., Yamada, H., Fujisawa, R., Bito, T., Harada, S., Fukunaga, A., Chantry, D., Gray, P.W., Morita, A., Suzuki, R., Tezuka, T., Ichihashi, M., Yoshie, O. IFN-gamma-inducible expression of thymus and activation-regulated chemokine/CCL17 and macrophage-derived chemokine/CCL22 in epidermal keratinocytes and their roles in atopic dermatitis. Int. Immunol. 14: 767-773, 2002   DOI   ScienceOn
13 Komine, M., Kakinuma T., Kagami, S., Hanakawa, Y., Hashimoto, K., Tamaki, K. Mechanism of thymus- and activation-regulated chemokine (TARC)/CCL17 production and its modulation by roxithromycin. J. Invest. Dermatol. 125: 491-498, 2005   DOI   ScienceOn
14 Pastore, S., Mascia, F., Mariotti, F., Dattilo, C., Mariani, V., Girolomoni, G. ERK1/2 regulates epidermal chemokine expression and skin inflammation. J. Immunol. 174: 5047-5056, 2005   DOI
15 Rossi, D., Zlotnik, A. The biology of chemokines and their receptors. Annu. Rev. Immunol. 18: 217-242, 2000   DOI   ScienceOn
16 Imai, T., Baba, M., Nishimura, M., Kakizaki, M., Takagi, S., Yoshie, O. The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J. Biol. Chem. 1272: 15036-15042, 1997
17 Li, Q., Verma, I.M. NF-kappaB regulation in the immune system. Nat. Rev., Immunol. 2: 725-734, 2002   DOI   ScienceOn
18 Bhat, N.R., Zhang, P., Lee, J.C., Hogan, E.L. Extracellular signal regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures. J. Neurosci. 18: 1633-1641, 1998   DOI
19 Chaturvedi, M.M., Mukhopadhyay, A., Aggarwal, B.B. Assay for redoxsensitive transcription factor. Methods Enzymol. 319: 585-602, 2000   DOI
20 Sallusto, F., Palermo, B., Lenig, D., Miettinen, M., Matikainen, S., Julkunen, I., Forster, R., Burgstahler, R., Lipp, M., Lanzavecchia, A. Distinct patterns and kinetics of chemokine production regulate dendritic cell function. Eur. J. Immunol. 29: 1617-1625, 1999   DOI   ScienceOn
21 Akdis, C.A., Akdis, M., Simon, D., Dibbert, B., Weber, M., Gratzl, S., Kreyden, O., Disch, R., Wuthrich, B., Blaser, K., Simon, H.U. T cells and T cell-derived cytokines as pathogenic factors in the nonallergic form of atopic dermatitis. J. Invest. Dermatol. 113: 628-634, 1999   DOI   ScienceOn
22 Kobayashi, M., Shimauchi, T., Hino, R., Tokura, Y. Roxithromycin downmodulates Th2 chemokine production by keratinocytes and chemokine receptor expression on Th2 cells: its dual inhibitory effects on the ligands and the receptors. Cell. Immunol. 228: 27-33, 2004   DOI   ScienceOn
23 Guha, M., Mackman, N. LPS induction of gene expression in human monocytes. Cell. Signal. 13: 85-94, 2001   DOI   ScienceOn
24 Barnes, P.J., Karin, M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336: 1066-1071, 1997   DOI   ScienceOn
25 Komine, M., Kakinuma, T, Kagami, S., Hanakawa, Y., Hashimoto, K., Tamaki, K. Mechanism of thymus- and activation-regulated chemokine (TARC)/CCL17 production and its modulation by roxithromycin. J. Invest. Dermatol. 125: 491-498, 2005   DOI   ScienceOn
26 Vestergaard, C., Yoneyama, H., Murai, M., Nakamura, K., Tamaki, K., Terashima, Y., Imai, T., Yoshie, O., Irimura, T., Mizutani, H., Matsushima, K. Overexpression of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. J. Clin. Invest. 104: 1097-1105, 1999   DOI   ScienceOn
27 Sandoval-Lopez, G., Teran, L.M. TARC: novel mediator of allergic inflammation. Clin. Exp. Allergy 31: 1809-1812, 2001   DOI   ScienceOn
28 Zhao, B., Stavchansky, S.A., Bowden, R.A., Bowman, P.D. Effect of interleukin-1beta and tumor necrosis factor-alpha on gene expression in human endothelial cells. Amer. J. Physiol. Cell Physiol. 284: C1577-C1583, 2003   DOI   ScienceOn
29 Chen, J.C., Ho, F.M., Chao, P.D.L., Chen, C.P., Jeng, K.C., Hsu, H.B., Lee, S.T., Wu, W.T, Lin, W.W. Inhibition of iNOS gene expression by quercetin is mediated by the inhibition of IkappaB kinase, nuclear factor-kappa B and STAT1, and depends on heme oxygenase-1 induction in mouse BV-2 microglia. Eur. J. Pharmacol. 521: 9-20, 2005   DOI
30 Nickel, R., Beck, L.A., Stellato, C., Schleimer, R.P. Chemokines and allergic disease. J. Allergy Clin. Immunol. 104: 723-742, 1999   DOI   ScienceOn
31 Akdis, C.A., Blaser, K., Akdis, M. Apoptosis in tissue inflammation and allergic disease. Curr. Opin. Immunol. 16: 717-723, 2004   DOI   ScienceOn
32 Thepen, T., Langeveld-Wildschut, E.G., Bihari, I.C., van Wichen, D.F., van Reijsen, F.C., Mudde, G.C., Bruijnzeel-Koomen, C.A. Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial TH2 response to a TH1 response in situ: an immunocytochemical study. J. Allergy Clin. Immunol. 97: 828-837, 1996   DOI   ScienceOn
33 Murphy, P.M., Baggioline, M., Charo, I.F., Hebert, C.A., Horuk, R., Matsushima, K., Miller, K., Miller, L.H., Oppenheim, J.J., Power, C.A. International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol. Rev. 52: 145-176, 2000
34 Campbell, J.J., Haraldsen, G., Pan, J., Rottman, J., Qin, S., Ponath, P., Andrew, D.P., Warneke, R., Ruffing, N., Kassam, N., Wu, L., Butcher, E.C. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature 400: 776-880, 1999   DOI   ScienceOn
35 Wang, X.C., Jobin, C., Allen, J.B., Roberts,W.L., Jaffe, G.J. Suppression of NF-kappaB-dependent proinflammatory gene expression in human RPE cells by a proteasome inhibitor. Invest. Ophthalmol. Vis. Sci. 40: 477-486, 1999
36 Ruland, J., Mak, T.W. Transducing signals from antigen receptors to nuclear factor kappaB. Immunol. Rev. 193: 93-100, 2003   DOI   ScienceOn
37 Bonecchi, R., Bianchi, G., Bordignon, P.P., D'Ambrosio, D., Lang, R., Borsatti, A., Sozzani, S., Allavena, P., Gray, P.A., Mantovani, A., Sinigaglia, F. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J. Exp. Med. 187: 129-134, 1998   DOI   ScienceOn
38 Jang, S.I., Kim, H.J., Kim, Y.J., Jeong, S.I., You, Y.O. Tanshinone IIA inhibits LPS-induced NF-kappaB activation in RAW 264.7 cells: possible involvement of the NIK-IKK, ERK1/2, p38 and JNK pathways. Eur J Pharmacol. 542: 1-7, 2006   DOI   ScienceOn
39 Galli, G., Chantry, D., Annunziato, F., Romagnani, P., Cosmi, L., Lazzeri, E., Raport, C.J., Galli, G., Manetti, R., Mavilia, C., Vanini, V., Chantry, D., Maggi, E., Romagnani, S. Macrophage-derived chemokine production by activated human T cells in vitro and in vivo: preferential association with the production of type 2 cytokines. Eur. J. Immunol. 30: 204-210, 2000   DOI   ScienceOn
40 Xiao, Y.Q., Malcolm, K., Worthen, G.S., Gardai, S., Schiemann, W. P.V., Fadok, A., Bratton, D.L., Henson, P.M. Cross-talk between ERK and p38 MAPK mediates selective suppression of pro-inflammatory cytokines by transforming growth factor-beta. J. Biol. Chem. 277: 14884-14893, 2002   DOI   ScienceOn
41 Trautmann, A., Akdis, M., Kleemann, D., Altznauer, F., Simon, H.U., Graeve, T., Noll, M., Brocker, E.B., Blaser, K., Akdis, C.A. T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis. J. Clin. Invest. 106: 25-35, 2000   DOI   ScienceOn
42 Vestergaard, C., Bang, K., Gesser, B., Yoneyama, H., Matsushima, K., Larsen, C.G. A Th2 chemokine, TARC, produced by keratinocytes may recruit CLA+CCR4+ lymphocytes into lesional atopic dermatitis skin. J. Invest. Dermatol. 115: 640-646, 2001   DOI   ScienceOn
43 Largo, R., Alvarez-Soria, M.A., Diez-Ortego, I, Calvo, E., Sanchez-Pernaute, O., Egido, J., Herrero-Beaumont, G. Glucosamine inhibits IL-1betainduced NFkappaB activation in human osteoarthritic chondrocytes. Osteoarthritis Cartil. 11: 290-298, 2003   DOI   ScienceOn
44 Imai, T., Chantry, D., Raport, C.J., Wood, C.L., Nishimura, M., Godiska, R., Yoshie, O., Gray, P.W. Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4. J. Biol. Chem. 273: 1764-1768, 1998   DOI   ScienceOn
45 Lim, B.O. Efficacy of wogonin in the production of immunoglobulins and cytokines by mesenteric lymph node lymphocytes in mouse colitis induced with dextran sulfate sodium. Biosci. Biotechnol. Biochem. 68: 2505-2511, 2004   DOI   ScienceOn
46 Imai, T., Baba, M., Nishimura, M., Kakizaki, M., Nishimura, M., Wang, J., Gray, P., Matsushima, K., Yoshie, O. Selective recruitment of CCR4bearing Th2 cells toward antigen-presenting cells by the CC chemokine thymus and activationregulated chemokine and macrophage-derived chemokine. Int. Immunol. 11: 81-88, 1999   DOI   ScienceOn